Allied Partners

The South �Ӱ�ֱ��n immunoGENomics Cancer Institute (SAiGENCI) will employ a collaborative approach to cancer research and care.

It will bring together clinicians, clinical and biomedical researchers, state and federal decision makers and the community.

CALHN and SAiGENCI

The Central Adelaide Local Health Network (CALHN) plays an important role in improving the health and wellbeing of South �Ӱ�ֱ��ns. It delivers world-class integrated healthcare, and general and quaternary hospital services.

CALHN has a strong commitment to the delivery of clinical services in an environment that is supportive of, and informed by, research across all disciplines.

CALHN’s involvement as an alliance partner in SAiGENCI is fundamental to the new Institute’s approach to building strong collaborative links between clinical and research communities. This partnership will lead to improved treatment and care options for South �Ӱ�ֱ��ns living with cancer.

The �Ӱ�ֱ�� of Adelaide and SAiGENCI

The �Ӱ�ֱ�� of Adelaide is consistently ranked in the top 1% of universities globally and is South �Ӱ�ֱ��’s only Group of Eight research intensive university.

One hundred percent of the �Ӱ�ֱ��’s research is rated 'world standard or above', with med-tech and health included as one of its primary research strengths.

With these credentials, the �Ӱ�ֱ�� of Adelaide is well placed to host SAiGENCI, and it has made a strong commitment to the collaborative creation of an ecosystem that will attract and retain the brightest minds in cancer research, boosting the cancer research capability in South �Ӱ�ֱ��.

It’s the �Ӱ�ֱ��’s mission to take an international leadership role in cancer research and innovation, and to support continuous improvements in health care delivery for those who battle cancer.